Vivos Therapeutics Receives Medicare Approval for VidaSleep(TM) Oral Appliance
(NASDAQ:VVOS), LITTLETON, Colo., July 01, 2025 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring, today announced that its VidaSleep(TM) oral appliance, featuring Vivos' patented and U.S. Food and Drug Administration (FDA) cleared Unilateral Bite Block technology, […]